Do analysts rate YI or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, YI or COSM?

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 111 $1.80B 0.02 -$9.65M -$1.40 N/A Cosmos Health $65.27M 0.21 -$19.15M -$0.64 N/A

Is YI or COSM more profitable?

111 has a net margin of -0.76% compared to Cosmos Health's net margin of -30.41%. 111's return on equity of 0.00% beat Cosmos Health's return on equity. Company Net Margins Return on Equity Return on Assets 111 -0.76% N/A -3.80% Cosmos Health -30.41% -52.85% -17.87%

Do analysts prefer WGRX or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer HKPD or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, HKPD or COSM?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $16.36M 0.28 -$1.14M N/A N/A Cosmos Health $65.27M 0.21 -$19.15M -$0.64 N/A

Do analysts prefer COSM or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, COSM or RDGT?

Ridgetech has higher revenue and earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.21 -$19.15M -$0.64 N/A Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Do analysts rate MCK or COSM?

McKesson presently has a consensus target price of $968.93, indicating a potential upside of 8.48%. Given McKesson's stronger consensus rating and higher probable upside, equities analysts plainly believe McKesson is more favorable than Cosmos Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.82 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, MCK or COSM?

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.90 Cosmos Health $65.27M 0.21 -$19.15M -$0.64 N/A

Is MCK or COSM more profitable?

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -30.41%. Cosmos Health's return on equity of -52.85% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Cosmos Health -30.41% -52.85% -17.87%

Cosmos Health (COSM) Competitors

$0.23 0.00 (0.00%)

As of 10:49 AM Eastern

Compare

COSM vs. YI, WGRX, HKPD, RDGT, and MCK

Should you buy Cosmos Health stock or one of its competitors? MarketBeat compares Cosmos Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cosmos Health include 111 (YI), Wellgistics Health (WGRX), Hong Kong Pharma Digital Technology (HKPD), Ridgetech (RDGT), and McKesson (MCK). These companies are all part of the "healthcare distributors" industry.

How does Cosmos Health compare to 111?

111 (NASDAQ:YI) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$1.80B	0.02	-$9.65M	-$1.40	N/A
Cosmos Health	$65.27M	0.21	-$19.15M	-$0.64	N/A

21.3% of 111 shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 43.9% of 111 shares are held by company insiders. Comparatively, 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

111 has a net margin of -0.76% compared to Cosmos Health's net margin of -30.41%. 111's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
111	-0.76%	N/A	-3.80%
Cosmos Health	-30.41%	-52.85%	-17.87%

In the previous week, 111's average media sentiment score of 0.00 equaled Cosmos Health'saverage media sentiment score.

Company	Overall Sentiment
111	Neutral
Cosmos Health	Neutral

111 has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, indicating that its stock price is 380% more volatile than the broader market.

Summary

111 beats Cosmos Health on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Wellgistics Health?

Wellgistics Health (NASDAQ:WGRX) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

Wellgistics Health has a beta of -1.47, meaning that its share price is 247% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, meaning that its share price is 380% more volatile than the broader market.

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.37	-$101.28M	-$44.50	N/A
Cosmos Health	$65.27M	0.21	-$19.15M	-$0.64	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Wellgistics Health's average media sentiment score of 0.00 equaled Cosmos Health'saverage media sentiment score.

Company	Overall Sentiment
Wellgistics Health	Neutral
Cosmos Health	Neutral

12.6% of Cosmos Health shares are held by institutional investors. 27.0% of Wellgistics Health shares are held by company insiders. Comparatively, 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cosmos Health has a net margin of -30.41% compared to Wellgistics Health's net margin of -545.69%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-545.69%	N/A	-145.69%
Cosmos Health	-30.41%	-52.85%	-17.87%

Summary

Cosmos Health beats Wellgistics Health on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$16.36M	0.28	-$1.14M	N/A	N/A
Cosmos Health	$65.27M	0.21	-$19.15M	-$0.64	N/A

In the previous week, Hong Kong Pharma Digital Technology had 1 more articles in the media than Cosmos Health. MarketBeat recorded 1 mentions for Hong Kong Pharma Digital Technology and 0 mentions for Cosmos Health. Hong Kong Pharma Digital Technology's average media sentiment score of 1.38 beat Cosmos Health's score of 0.00 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
Cosmos Health	Neutral

12.6% of Cosmos Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -30.41%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Cosmos Health	-30.41%	-52.85%	-17.87%

Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its stock price is 133% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, meaning that its stock price is 380% more volatile than the broader market.

Summary

Hong Kong Pharma Digital Technology beats Cosmos Health on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Ridgetech?

Cosmos Health (NASDAQ:COSM) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Ridgetech has a net margin of 0.00% compared to Cosmos Health's net margin of -30.41%. Ridgetech's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-30.41%	-52.85%	-17.87%
Ridgetech	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ridgetech had 1 more articles in the media than Cosmos Health. MarketBeat recorded 1 mentions for Ridgetech and 0 mentions for Cosmos Health. Cosmos Health's average media sentiment score of 0.00 equaled Ridgetech'saverage media sentiment score.

Company	Overall Sentiment
Cosmos Health	Neutral
Ridgetech	Neutral

12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 26.2% of Cosmos Health shares are held by insiders. Comparatively, 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

Ridgetech has higher revenue and earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.21	-$19.15M	-$0.64	N/A
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

Summary

Ridgetech beats Cosmos Health on 7 of the 10 factors compared between the two stocks.

How does Cosmos Health compare to McKesson?

McKesson (NYSE:MCK) and Cosmos Health (NASDAQ:COSM) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

McKesson has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market.

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.90
Cosmos Health	$65.27M	0.21	-$19.15M	-$0.64	N/A

In the previous week, McKesson had 52 more articles in the media than Cosmos Health. MarketBeat recorded 52 mentions for McKesson and 0 mentions for Cosmos Health. McKesson's average media sentiment score of 0.96 beat Cosmos Health's score of 0.00 indicating that McKesson is being referred to more favorably in the media.

Company	Overall Sentiment
McKesson	Positive
Cosmos Health	Neutral

McKesson presently has a consensus target price of $968.93, indicating a potential upside of 8.48%. Given McKesson's stronger consensus rating and higher probable upside, equities analysts plainly believe McKesson is more favorable than Cosmos Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -30.41%. Cosmos Health's return on equity of -52.85% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Cosmos Health	-30.41%	-52.85%	-17.87%

85.1% of McKesson shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 26.2% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

McKesson beats Cosmos Health on 13 of the 16 factors compared between the two stocks.

Get Cosmos Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COSM vs. The Competition

Export

Metric	Cosmos Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13.99M	$10.05B	$7.02B	$12.96B
Dividend Yield	N/A	2.55%	2.58%	10.20%
P/E Ratio	-0.36	25.57	269.90	24.97
Price / Sales	0.21	4.83	659.13	107.89
Price / Cash	N/A	25.58	28.89	37.44
Price / Book	0.52	5.32	11.29	6.44
Net Income	-$19.15M	$309.96M	$3.45B	$347.50M
7 Day Performance	-0.85%	0.86%	3.56%	3.82%
1 Month Performance	-20.40%	0.29%	-0.57%	-0.37%
1 Year Performance	-70.78%	23.75%	77.67%	23.81%

Cosmos Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COSM Cosmos Health	1.4701 of 5 stars	$0.23 flat	N/A	-70.8%	$13.99M	$65.27M	N/A	100	Upcoming Earnings Gap Up
YI 111	0.3988 of 5 stars	$3.86 +6.6%	N/A	-43.0%	$33.93M	$1.80B	N/A	1,063	Gap Down
WGRX Wellgistics Health	0.4015 of 5 stars	$3.46 -1.7%	N/A	-91.4%	$8.69M	$23.34M	N/A	31	Gap Down High Trading Volume
HKPD Hong Kong Pharma Digital Technology	0.6622 of 5 stars	$0.42 +2.5%	N/A	-62.2%	$4.62M	$16.36M	N/A	19	Earnings Report
RDGT Ridgetech	0.4872 of 5 stars	$0.72 -5.4%	N/A	-99.6%	$650K	$132.16M	N/A	980	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COSM) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cosmos Health (COSM) Competitors

COSM vs. YI, WGRX, HKPD, RDGT, and MCK

How does Cosmos Health compare to 111?

Summary

How does Cosmos Health compare to Wellgistics Health?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Cosmos Health compare to Ridgetech?

Summary

How does Cosmos Health compare to McKesson?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cosmos Health (COSM) Competitors

COSM vs. YI, WGRX, HKPD, RDGT, and MCK

How does Cosmos Health compare to 111?

Do analysts rate YI or COSM?

Which has higher earnings and valuation, YI or COSM?

Do insiders and institutionals hold more shares of YI or COSM?

Is YI or COSM more profitable?

Does the media prefer YI or COSM?

Which has more risk & volatility, YI or COSM?

Summary

How does Cosmos Health compare to Wellgistics Health?

Which has more volatility and risk, WGRX or COSM?

Which has better earnings & valuation, WGRX or COSM?

Do analysts prefer WGRX or COSM?

Does the media favor WGRX or COSM?

Do institutionals and insiders hold more shares of WGRX or COSM?

Is WGRX or COSM more profitable?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Do analysts prefer HKPD or COSM?

Which has higher earnings and valuation, HKPD or COSM?

Does the media prefer HKPD or COSM?

Do insiders & institutionals believe in HKPD or COSM?

Is HKPD or COSM more profitable?

Which has more volatility and risk, HKPD or COSM?

Summary

How does Cosmos Health compare to Ridgetech?

Is COSM or RDGT more profitable?

Do analysts prefer COSM or RDGT?

Does the media favor COSM or RDGT?

Do institutionals & insiders believe in COSM or RDGT?

Which has more risk and volatility, COSM or RDGT?

Which has better earnings & valuation, COSM or RDGT?

Summary

How does Cosmos Health compare to McKesson?

Which has more volatility & risk, MCK or COSM?

Which has stronger valuation and earnings, MCK or COSM?

Does the media favor MCK or COSM?

Do analysts rate MCK or COSM?

Is MCK or COSM more profitable?

Do institutionals & insiders have more ownership in MCK or COSM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools